Catalyst Wire Dossier Catalyst Wire Dossier

VR040 (inhaled apomorphine)

apomorphine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VR040 (inhaled apomorphine), covering 2012-09-11 to 2012-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease [Phase 2]

See pricing